Quality of life (QoL) and symptoms in transfusion-dependent patients with myelodysplastic syndromes (MDS) undergoing oral chelation therapy

被引：0
|
作者：
Efficace, Fabio [1 ]
Cottone, Francesco [1 ]
Vignetti, Marco [2 ]
Mandelli, Franco [1 ]
Angelucci, Emanuele [3 ]
机构：
[1] GIMEMA, Italian Grp Adult Hematol Dis, Rome, Italy
[2] GIMEMA Data Ctr, Hlth Outcomes Res Unit, Rome, Italy
[3] Osped Oncol Riferimento Reg A Businco, Rome, Italy
来源：
QUALITY OF LIFE RESEARCH | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
3092
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes
    Michel Delforge
    Dominik Selleslag
    Agnès Triffet
    Philippe Mineur
    Greet Bries
    Carlos Graux
    Fabienne Trullemans
    Karen MacDonald
    Ivo Abraham
    Wim Pluymers
    Christophe Ravoet
    Annals of Hematology, 2011, 90 : 655 - 666
  • [32] Deferiprone is useful in blood transfusion-dependent patients affected by myelodysplastic syndrome (MDS)
    Russolillo, S.
    Izzo, G. Nitrato
    Esposito, M.
    Improta, S.
    Lucania, A.
    Villa, M. R.
    Mastrullo, L.
    LEUKEMIA RESEARCH, 2007, 31 : S137 - S137
  • [33] Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes A Randomized Trial
    Angelucci, Emanuele
    Li, Junmin
    Greenberg, Peter
    Wu, Depei
    Hou, Ming
    Montano Figueroa, Efreen Horacio
    Guadalupe Rodriguez, Maria
    Dong, Xunwei
    Ghosh, Jagannath
    Izquierdo, Miguel
    Garcia-Manero, Guillermo
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (08) : 513 - +
  • [34] IRON CHELATION THERAPY IN MYELODYSPLASTIC SYNDROMES AND IN OTHER TRANSFUSION-DEPENDENT CHRONIC ANEMIAS. RETROSPECTIVE STUDY OF 69 PATIENTS FROM A SINGLE INSTITUTION
    Finelli, C.
    Clissa, C.
    Barraco, M.
    De Maio, C.
    Stanzani, M.
    Parisi, S.
    Paolini, S.
    Bosi, C.
    Cavo, M.
    HAEMATOLOGICA, 2017, 102 : 770 - 771
  • [35] Health-Related Quality Of Life In Transfusion-Dependent Patients With Myelodysplastic Syndromes Treated With Deferasirox. A Multicenter Prospective Study
    Efficace, Fabio
    Santini, Valeria
    La Nasa, Giorgio
    Cottone, Francesco
    Finelli, Carlo
    Borin, Lorenza
    Quaresmini, Giulia
    Di Tucci, Anna
    Volpe, Antonio
    Cilloni, Daniela
    Quarta, Giovanni
    Sanpaolo, Grazia
    Rivellini, Flavia
    Salvi, Flavia
    Molteni, Alfredo
    Vallisa, Daniele
    Storti, Sergio
    Voso, Maria Teresa
    Alimena, Giuliana
    Fenu, Susanna
    Vignetti, Marco
    Mandelli, Franco
    Angelucci, Emanuele
    BLOOD, 2013, 122 (21)
  • [36] Cost-effectiveness analysis of oral iron chelation therapy with deferasirox (Exjade®, ICL670) versus infusional chelation therapy with deferoxamine in patients with transfusion-dependent myelodysplastic
    Delea, TE
    Thomas, SK
    Baladi, JF
    Phatak, PD
    BLOOD, 2005, 106 (11) : 484B - 485B
  • [37] Optimising management of deferasirox therapy for patients with transfusion-dependent thalassaemia and lower-risk myelodysplastic syndromes
    Kattamis, Antonis
    Aydinok, Yesim
    Taher, Ali
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 272 - 282
  • [38] Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients
    Oliva, Esther Natalie
    Ronco, Francesca
    Marino, Antonio
    Alati, Caterina
    Pratico, Giulia
    Nobile, Francesco
    TRANSFUSION, 2010, 50 (07) : 1568 - 1570
  • [39] Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO study
    Sarocchi, Matteo
    Li, Junmin
    Li, Xiao
    Wu, Depei
    Figueroa, Efreen Montano
    Rodriguez, Maria Guadalupe
    Hou, Ming
    Finelli, Carlo
    Shi, Hong-Xia
    Xiao, Zhijian
    Oliva, Esther Natalie
    Kyuchukova, Liana Gercheva
    Drummond, Mark
    Symeonidis, Argiris
    Velazquez, Eric J.
    Rivoli, Giulia
    Izquierdo, Miguel
    Kolekar, Yogita
    Spallarossa, Paolo
    Angelucci, Emanuele
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (05) : 2049 - 2056
  • [40] COMBINED CHELATION THERAPY WITH DEFERASIROX AND DEFEROXAMINE IN TRANSFUSION-DEPENDENT PATIENTS WITH THALASSEMIA
    Ladis, V.
    Delaporta, P.
    Kyriakopoulou, D.
    Kattamis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 703 - 703
12345